262.2K XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Russell Barton | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 1.61 per share. | 21 Jan 2025 | 2,914 | 136,117 | - | 1.6 | 4,692 | Common Stock |
| Eric Siemers | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.59 per share. | 21 Jan 2025 | 3,219 | 170,298 | - | 1.6 | 5,118 | Common Stock |
| Daniel O'Connell | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.59 per share. | 21 Jan 2025 | 12,619 | 667,488 | - | 1.6 | 20,102 | Common Stock |
| Derek M. Meisner | Chief Legal Officer & Corp Sec | Sale of securities on an exchange or to another person at price $ 1.59 per share. | 21 Jan 2025 | 3,418 | 161,127 | - | 1.6 | 5,435 | Common Stock |
| James J. Doherty | President and CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 93,300 | 93,300 | - | - | Employee Stock Option (right to buy) | |
| James J. Doherty | President and CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 62,600 | 62,600 | - | 0 | Common Stock | |
| Amy Schacterle | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 13,200 | 13,200 | - | - | Employee Stock Option (right to buy) | |
| Amy Schacterle | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 8,800 | 8,800 | - | 0 | Common Stock | |
| Daniel O'Connell | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 338,000 | 338,000 | - | - | Employee Stock Option (right to buy) | |
| Derek M. Meisner | Chief Legal Officer & Corp Sec | Sale of securities on an exchange or to another person at price $ 1.84 per share. | 03 Jan 2025 | 11,122 | 97,745 | - | 1.8 | 20,506 | Common Stock |
| Derek M. Meisner | Chief Legal Officer & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 66,800 | 164,545 | - | 0 | Common Stock | |
| Derek M. Meisner | Chief Legal Officer & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 100,300 | 100,300 | - | - | Employee Stock Option (right to buy) | |
| Daniel O'Connell | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.84 per share. | 03 Jan 2025 | 47,778 | 454,707 | - | 1.8 | 87,873 | Common Stock |
| Daniel O'Connell | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 225,400 | 680,107 | - | 0 | Common Stock | |
| Eric Siemers | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.85 per share. | 03 Jan 2025 | 10,859 | 106,717 | - | 1.8 | 20,047 | Common Stock |
| Eric Siemers | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 66,800 | 173,517 | - | 0 | Common Stock | |
| Eric Siemers | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 100,300 | 100,300 | - | - | Employee Stock Option (right to buy) | |
| Russell Barton | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 74,700 | 74,700 | - | - | Employee Stock Option (right to buy) | |
| Russell Barton | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 49,800 | 139,031 | - | 0 | Common Stock | |
| Russell Barton | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 1.86 per share. | 03 Jan 2025 | 7,636 | 89,231 | - | 1.9 | 14,225 | Common Stock |
| Amy Schacterle | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2024 | 340,000 | 340,000 | - | - | Employee Stock Option (right to buy) | |
| Nathan B. Fountain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Jeffrey L. Ives | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Derrell D. Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Laura Stoppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Sean Stalfort | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Doherty J. James | President and CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 601,000 | 601,000 | - | - | Employee Stock Option (right to buy) | |
| O'Connell Daniel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.47 per share. | 19 Jan 2024 | 15,200 | 502,485 | - | 3.5 | 52,753 | Common Stock |
| Derek M. Meisner | Chief Legal Officer & Corp Sec | Sale of securities on an exchange or to another person at price $ 3.48 per share. | 19 Jan 2024 | 8,933 | 108,867 | - | 3.5 | 31,048 | Common Stock |
| Barton Russell | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 3.73 per share. | 18 Jan 2024 | 2,833 | 96,867 | - | 3.7 | 10,555 | Common Stock |
| Siemers Eric | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.71 per share. | 18 Jan 2024 | 3,124 | 117,576 | - | 3.7 | 11,604 | Common Stock |
| O'Connell Daniel | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 602,000 | 602,000 | - | - | Employee Stock Option (right to buy) | |
| Siemers Eric | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 141,000 | 141,000 | - | - | Employee Stock Option (right to buy) | |
| Barton Russell | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 110,000 | 110,000 | - | - | Employee Stock Option (right to buy) | |
| Barton Russell | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 73,000 | 99,700 | - | 0 | Common Stock | |
| Daniel O'Connell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 401,000 | 517,685 | - | 0 | Common Stock | |
| Meisner Derek M. | Chief Legal Officer & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 91,000 | 117,800 | - | 0 | Common Stock | |
| M. Derek Meisner | Chief Legal Officer & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 137,000 | 137,000 | - | - | Employee Stock Option (right to buy) | |
| Siemers Eric | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 94,000 | 120,700 | - | 0 | Common Stock | |
| Sean Stalfort | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Nathan B. Fountain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Laura Stoppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Derrell D. Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Jeffrey L. Ives | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Russell Barton | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 26,700 | 26,700 | - | 0 | Common Stock | |
| Russell Barton | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 120,200 | 120,200 | - | - | Employee Stock Option (right to buy) | |
| Eric Siemers | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 120,200 | 120,200 | - | - | Employee Stock Option (right to buy) | |
| Eric Siemers | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 26,700 | 26,700 | - | 0 | Common Stock | |
| Daniel O'Connell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 472,500 | 472,500 | - | - | Employee Stock Option (right to buy) | |
| Daniel O'Connell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 114,000 | 116,685 | - | 0 | Common Stock | |
| Derek M. Meisner | Chief Legal Office & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 120,800 | 120,800 | - | - | Employee Stock Option (right to buy) | |
| Derek M. Meisner | Chief Legal Office & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 26,800 | 26,800 | - | 0 | Common Stock | |
| Derrell D. Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 50,000 | 50,000 | - | - | Stock Option Grant (right to buy) | |
| Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Jeffrey L. Ives | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Sean Stalfort | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Jeffrey Sevigny | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Nathan B. Fountain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Laura Stoppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 50,000 | 50,000 | - | - | Stock Option Grant (right to buy) | |
| Daniel O'Connell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 455,000 | 455,000 | - | - | Employee Stock Option (right to buy) | |
| Eric Siemers | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 90,000 | 90,000 | - | - | Employee Stock Option (right to buy) | |
| Russell Barton | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 135,000 | 135,000 | - | - | Employee Stock Option (right to buy) | |
| Daniel O'Connell | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.47 per share. | 30 Nov 2021 | 1,118 | 2,685 | - | 4.5 | 4,997 | Common Stock |
| Daniel O'Connell | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2021 | 1,118 | 0 | - | - | Stock Option (Right to Buy) | |
| Daniel O'Connell | Director, President and CEO | 06 Jul 2021 | 123 | 0 | - | - | Series A Preferred Stock | ||
| Sean Stalfort | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 06 Jul 2021 | 35,000 | 172,324 | - | 16 | 560,000 | Common Stock |
| Sean Stalfort | Director | 06 Jul 2021 | 130,180 | 137,324 | - | - | Common Stock | ||
| Sean Stalfort | Director | 06 Jul 2021 | 130,180 | 0 | - | - | Series A-1 Preferred | ||
| Sean Stalfort | Director | 06 Jul 2021 | 131,595 | 131,595 | - | - | Common Stock | ||
| Sean Stalfort | Director | 06 Jul 2021 | 131,595 | 0 | - | - | Series B Preferred | ||
| Daniel O'Connell | Director, President and CEO | 06 Jul 2021 | 35 | 1,577 | - | 4.5 | 156 | Common Stock | |
| Daniel O'Connell | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2021 | 35 | 0 | - | - | Warrant (Right to Buy) | |
| Daniel O'Connell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.00 per share. | 06 Jul 2021 | 10 | 1,567 | - | 16 | 160 | Common Stock |
| Daniel O'Connell | Director, President and CEO | 06 Jul 2021 | 123 | 1,542 | - | - | Common Stock | ||
| Nathan B. Fountain | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 06 Jul 2021 | 6,250 | 6,250 | - | 16 | 100,000 | Common Stock |
| Nathan B. Fountain | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 06 Jul 2021 | 6,250 | 6,250 | - | 16 | 100,000 | Common Stock |
| Laura Stoppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 34,000 | 34,000 | - | - | Stock Option (Right to Buy) | |
| Jeffrey L. Ives | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 34,000 | 34,000 | - | - | Stock Option (Right to Buy) | |
| Sean Stalfort | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 34,000 | 34,000 | - | - | Stock Option (Right to Buy) | |
| Jeffrey Sevigny | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 34,000 | 34,000 | - | - | Stock Option (Right to Buy) | |
| Nathan B. Fountain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 34,000 | 34,000 | - | - | Stock Option (Right to Buy) |